Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at ...

High-dose HCQ use may lower the risk for diabetes among patients with pSS and can potentially mitigate the diabetogenic effects of glucocorticoids.

Hashimoto thyroiditis demonstrated a strong familial association between first-, second-, and third-degree relatives, especially among women.